Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (Q47609376)

4 February 2018

title

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant. (English)

1 reference

4 February 2018

1 reference

1 reference

1 reference

16

Litzow MR

1 reference

4 February 2018

Richard E Champlin

10

object named as

Champlin RE

1 reference

4 February 2018

Sergio Giralt

2

object named as

Giralt SA

1 reference

4 February 2018

author name string

Eapen M

1

1 reference

4 February 2018

Horowitz MM

3

1 reference

4 February 2018

Klein JP

4

1 reference

4 February 2018

Wagner JE

5

1 reference

4 February 2018

Zhang MJ

6

1 reference

4 February 2018

Tallman MS

7

1 reference

4 February 2018

Marks DI

8

1 reference

4 February 2018

Camitta BM

9

1 reference

4 February 2018

Ringdén O

11

1 reference

4 February 2018

Bredeson CN

12

1 reference

4 February 2018

Martino R

13

1 reference

4 February 2018

Gale RP

14

1 reference

4 February 2018

Cairo MS

15

1 reference

4 February 2018

deLima M

17

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 October 2004

1 reference

4 February 2018

Bone Marrow Transplantation

published in

1 reference

4 February 2018

volume

34

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

page(s)

721-727

1 reference

4 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704645

exact match

0 references

cites work

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now stand.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

Quantification of the completeness of follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Second transplants for leukaemic relapse after bone marrow transplantation: high early mortality but favourable effect of chronic GVHD on continued remission. A report by the EBMT Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Second allogeneic bone marrow transplantation in acute leukemia: a multicenter study from the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Second allogeneic bone marrow transplantation for post-transplant leukemia relapse: results of a survey of 66 cases in 24 Japanese institutes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de Moelle (SFGM)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704645

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704645

1 reference

4 February 2018

PubMed ID

15322568

1 reference

4 February 2018